[
    [
        {
            "time": "2021-06-02",
            "original_text": "富时罗素季度调整结果公布，速看新增剔除A股标的全名单",
            "features": {
                "keywords": [
                    "富时罗素",
                    "季度调整",
                    "新增",
                    "剔除",
                    "A股"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "富时罗素季度调整结果公布，速看新增剔除A股标的全名单",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-06-18",
            "original_text": "富时中国A50新纳入、剔除各2只A股，6月18日收盘后生效",
            "features": {
                "keywords": [
                    "富时中国A50",
                    "纳入",
                    "剔除",
                    "金龙鱼",
                    "智飞生物",
                    "恒力石化",
                    "中公教育"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "富时中国A50新纳入、剔除各2只A股，6月18日收盘后生效",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-06-02",
            "original_text": "A股资金流向（6月2日）：资金大幅出逃，医药板块成“重灾区”",
            "features": {
                "keywords": [
                    "A股",
                    "资金流向",
                    "医药板块",
                    "重灾区"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股资金流向（6月2日）：资金大幅出逃，医药板块成“重灾区”",
                "Correlation": 7,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-06-02",
            "original_text": "新冠检测及疫苗板块回调，热景生物跌超13%",
            "features": {
                "keywords": [
                    "新冠检测",
                    "疫苗",
                    "回调",
                    "热景生物"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "新冠检测及疫苗板块回调，热景生物跌超13%",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-06-02",
            "original_text": "医药行业周报：建议持续关注创新药等高景气领域相关优质企业",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "创新药",
                    "高景气领域"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业周报：建议持续关注创新药等高景气领域相关优质企业",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-06-02",
            "original_text": "中泰证券：新冠疫苗接种加速推进，商业化价值有望从二季度开始兑现",
            "features": {
                "keywords": [
                    "中泰证券",
                    "新冠疫苗",
                    "接种",
                    "商业化价值",
                    "二季度"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中泰证券：新冠疫苗接种加速推进，商业化价值有望从二季度开始兑现",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]